Literature DB >> 32891517

Antidepressant-like effects of URB597 and JZL184 in male and female rats exposed to early life stress.

Shirley Alteba1, Tomer Mizrachi Zer-Aviv1, Adi Tenenhaus2, Gilad Ben David2, Jacob Adelman3, Cecilia J Hillard3, Ravid Doron2, Irit Akirav4.   

Abstract

Early life stress (ELS) may increase predisposition to depression. Despite extensive research, there is still a lack of knowledge of how to optimally treat depression. We aimed to establish a role for the endocannabinoid (ECB) system within the hippocampal-nucleus accumbens (NAc) network as a possible effective target in combating the pathophysiological development of depression-like behavior and neuronal alterations that are precipitated by ELS. Male and female rats were exposed to ELS during post-natal days (P) 7-14, injected with the fatty acid amide hydrolase (FAAH) inhibitor URB597 or the monoacylglycerol lipase (MAGL) inhibitor JZL184 for 2 weeks during late-adolescence (P45-60). Rats were tested starting at P90 for depressive- and anxiety-like behaviors as well as social preference and recognition; alterations in FAAH and MAGL activity; the expression of brain-derived neurotrophic factor (BDNF); and plasticity in the hippocampal-NAc pathway. FAAH and MAGL inhibitors during late-adolescence prevented: (i) the long-term effects of ELS on depression- and anxiety-like behavior and the impairment in social behavior and neuronal plasticity in males and females; (ii) ELS-induced alterations in MAGL activity in males' hippocampus and females' hippocampus and NAc; and (iii) ELS-induced alterations in BDNF in males' hippocampus and NAc and females' hippocampus. Significant correlations were observed between alterations in MAGL and BDNF levels and the behavioral phenotype. The findings suggest that alterations in MAGL activity and BDNF expression in the hippocampal-NAc network contribute to the depressive-like behavioral phenotype in ELS males and females. Moreover, the study suggests FAAH and MAGL inhibitors as potential intervention drugs for depression.
Copyright © 2020 Elsevier B.V. and ECNP. All rights reserved.

Entities:  

Keywords:  Depression; Endocannabinoids; Rats

Year:  2020        PMID: 32891517     DOI: 10.1016/j.euroneuro.2020.08.005

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  5 in total

Review 1.  On the Biomedical Properties of Endocannabinoid Degradation and Reuptake Inhibitors: Pre-clinical and Clinical Evidence.

Authors:  Karen Jaqueline Paredes-Ruiz; Karla Chavira-Ramos; Mario Orozco-Morales; Cimen Karasu; Alexey A Tinkov; Michael Aschner; Abel Santamaría; Ana Laura Colín-González
Journal:  Neurotox Res       Date:  2021-11-06       Impact factor: 3.911

Review 2.  Modulation of Endocannabinoid System Components in Depression: Pre-Clinical and Clinical Evidence.

Authors:  Uri Bright; Irit Akirav
Journal:  Int J Mol Sci       Date:  2022-05-15       Impact factor: 6.208

3.  Anandamide Hydrolysis Inhibition Reverses the Long-Term Behavioral and Gene Expression Alterations Induced by MK-801 in Male Rats: Differential CB1 and CB2 Receptor-Mediated Effects.

Authors:  Hagar Bauminger; Hiba Zaidan; Irit Akirav; Inna Gaisler-Salomon
Journal:  Schizophr Bull       Date:  2022-06-21       Impact factor: 7.348

Review 4.  Do Adolescent Exposure to Cannabinoids and Early Adverse Experience Interact to Increase the Risk of Psychiatric Disorders: Evidence from Rodent Models.

Authors:  Anna Portugalov; Irit Akirav
Journal:  Int J Mol Sci       Date:  2021-01-13       Impact factor: 5.923

5.  Fatty Acid Amide Hydrolase (FAAH) Inhibition Plays a Key Role in Counteracting Acute Lung Injury.

Authors:  Tiziana Genovese; Andrea Duranti; Ramona D'Amico; Roberta Fusco; Daniela Impellizzeri; Alessio Filippo Peritore; Rosalia Crupi; Enrico Gugliandolo; Salvatore Cuzzocrea; Rosanna Di Paola; Rosalba Siracusa; Marika Cordaro
Journal:  Int J Mol Sci       Date:  2022-03-03       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.